Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Tebaldi

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Journal of the American College of Cardiology|August 31, 2025
Computed Tomography Angiography or Standard Care After Left Main PCI?Fabrizio D'Ascenzo, Enrico Cerrato, Ovidio De Filippo, et al.
REC, Interventional Cardiology|May 29, 2025
Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trialPablo Vidal-Calés, Kamil Bujak, Riccardo Rinaldi, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
The New England Journal of Medicine|August 27, 2023
Complete or Culprit-Only PCI in Older Patients with Myocardial InfarctionSimone Biscaglia, Vincenzo Guiducci, Javier Escaned, et al.
Journal of the American College of Cardiology|March 5, 2021
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial InfarctionSalvatore Brugaletta, Josep Gomez-Lara, Luis Ortega-Paz, et al.
JACC. Cardiovascular Interventions|August 25, 2022
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND TrialRami Gabani, Francesco Spione, Victor Arevalos, et al.
American Heart Journal|February 21, 2025
Functional coronary angiography to indicate and guide revascularization in STEMI patients with multivessel disease: Rationale and design of the AIR-STEMI trialAndrea Erriquez, Iginio Colaiori, Abdul Hakeem, et al.
The American Journal of Cardiology|December 22, 2022
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)Victor Arévalos, Francesco Spione, Rami Gabani, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Journal of the American College of Cardiology|August 31, 2025
Computed Tomography Angiography or Standard Care After Left Main PCI?Fabrizio D'Ascenzo, Enrico Cerrato, Ovidio De Filippo, et al.
REC, Interventional Cardiology|May 29, 2025
Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trialPablo Vidal-Calés, Kamil Bujak, Riccardo Rinaldi, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
The New England Journal of Medicine|August 27, 2023
Complete or Culprit-Only PCI in Older Patients with Myocardial InfarctionSimone Biscaglia, Vincenzo Guiducci, Javier Escaned, et al.
Journal of the American College of Cardiology|March 5, 2021
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial InfarctionSalvatore Brugaletta, Josep Gomez-Lara, Luis Ortega-Paz, et al.
JACC. Cardiovascular Interventions|August 25, 2022
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND TrialRami Gabani, Francesco Spione, Victor Arevalos, et al.
American Heart Journal|February 21, 2025
Functional coronary angiography to indicate and guide revascularization in STEMI patients with multivessel disease: Rationale and design of the AIR-STEMI trialAndrea Erriquez, Iginio Colaiori, Abdul Hakeem, et al.
The American Journal of Cardiology|December 22, 2022
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)Victor Arévalos, Francesco Spione, Rami Gabani, et al.
Pageof 12